Device type · SBB
System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
SBB
Pathology
Device class
Class III
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection
- Product code
- SBB
- Device class
- Class III
- Review panel
- Pathology
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for SBB
Latest FDA decisions
- ColoSense®BreakthroughPMA
P230001 · Decided May 3, 2024 · 469 days after receipt
Device type: System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection (SBB) · Laboratory Medicine & Pathology
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- ColoSense Test Kit, Part No. 80-001, component of ColoSense testOpen, Classified
Z-2077-2025 · Started May 20, 2025 · Posted by FDA Jul 3, 2025
Reason given: Multiple plate failures documented as a result of the Low Positive Template Control being too high and out of range using the affected lot of ColoSense Test Kit.
Cause as FDA categorized it: Unknown/Undetermined by firm
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.